202 related articles for article (PubMed ID: 7496173)
1. A new mutation associated with MELAS is located in a mitochondrial DNA polypeptide-coding gene.
Manfredi G; Schon EA; Moraes CT; Bonilla E; Berry GT; Sladky JT; DiMauro S
Neuromuscul Disord; 1995 Sep; 5(5):391-8. PubMed ID: 7496173
[TBL] [Abstract][Full Text] [Related]
2. Identification of a novel mutation in the mtDNA ND5 gene associated with MELAS.
Santorelli FM; Tanji K; Kulikova R; Shanske S; Vilarinho L; Hays AP; DiMauro S
Biochem Biophys Res Commun; 1997 Sep; 238(2):326-8. PubMed ID: 9299505
[TBL] [Abstract][Full Text] [Related]
3. Isolated cytochrome c oxidase deficiency as a cause of MELAS.
Rossmanith W; Freilinger M; Roka J; Raffelsberger T; Moser-Thier K; Prayer D; Bernert G; Bittner RE
J Med Genet; 2008 Feb; 45(2):117-21. PubMed ID: 18245391
[TBL] [Abstract][Full Text] [Related]
4. The role of complex I genes in MELAS: a novel heteroplasmic mutation 3380G>A in ND1 of mtDNA.
Horváth R; Reilmann R; Holinski-Feder E; Ringelstein EB; Klopstock T
Neuromuscul Disord; 2008 Jul; 18(7):553-6. PubMed ID: 18590963
[TBL] [Abstract][Full Text] [Related]
5. Revelation of a new mitochondrial DNA mutation (G12147A) in a MELAS/MERFF phenotype.
Melone MA; Tessa A; Petrini S; Lus G; Sampaolo S; di Fede G; Santorelli FM; Cotrufo R
Arch Neurol; 2004 Feb; 61(2):269-72. PubMed ID: 14967777
[TBL] [Abstract][Full Text] [Related]
6. Atypical clinical presentations associated with the MELAS mutation at position 3243 of human mitochondrial DNA.
Moraes CT; Ciacci F; Silvestri G; Shanske S; Sciacco M; Hirano M; Schon EA; Bonilla E; DiMauro S
Neuromuscul Disord; 1993 Jan; 3(1):43-50. PubMed ID: 8392410
[TBL] [Abstract][Full Text] [Related]
7. An mtDNA mutation, 14453G-->A, in the NADH dehydrogenase subunit 6 associated with severe MELAS syndrome.
Ravn K; Wibrand F; Hansen FJ; Horn N; Rosenberg T; Schwartz M
Eur J Hum Genet; 2001 Oct; 9(10):805-9. PubMed ID: 11781695
[TBL] [Abstract][Full Text] [Related]
8. Increased mitochondrial DNA in blood vessels and ragged-red fibers in mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS).
Tokunaga M; Mita S; Sakuta R; Nonaka I; Araki S
Ann Neurol; 1993 Mar; 33(3):275-80. PubMed ID: 7684581
[TBL] [Abstract][Full Text] [Related]
9. Clinical features of MELAS and mitochondrial DNA mutations.
Goto Y
Muscle Nerve Suppl; 1995; 3():S107-12. PubMed ID: 7603510
[TBL] [Abstract][Full Text] [Related]
10. Functional mitochondrial heterogeneity in heteroplasmic cells carrying the mitochondrial DNA mutation associated with the MELAS syndrome (mitochondrial encephalopathy, lactic acidosis, and strokelike episodes).
Bakker A; Barthélémy C; Frachon P; Chateau D; Sternberg D; Mazat JP; Lombès A
Pediatr Res; 2000 Aug; 48(2):143-50. PubMed ID: 10926287
[TBL] [Abstract][Full Text] [Related]
11. Is the mitochondrial complex I ND5 gene a hot-spot for MELAS causing mutations?
Liolitsa D; Rahman S; Benton S; Carr LJ; Hanna MG
Ann Neurol; 2003 Jan; 53(1):128-32. PubMed ID: 12509858
[TBL] [Abstract][Full Text] [Related]
12. A mitochondrial tRNA(Lys) gene mutation (T8316C) in a patient with mitochondrial myopathy, lactic acidosis, and stroke-like episodes.
Campos Y; Lorenzo G; Martín MA; Torregrosa A; del Hoyo P; Rubio JC; García A; Arenas J
Neuromuscul Disord; 2000 Oct; 10(7):493-6. PubMed ID: 10996780
[TBL] [Abstract][Full Text] [Related]
13. Novel mitochondrial DNA ND5 mutation in a patient with clinical features of MELAS and MERRF.
Naini AB; Lu J; Kaufmann P; Bernstein RA; Mancuso M; Bonilla E; Hirano M; DiMauro S
Arch Neurol; 2005 Mar; 62(3):473-6. PubMed ID: 15767514
[TBL] [Abstract][Full Text] [Related]
14. A MERRF/MELAS overlap syndrome associated with a new point mutation in the mitochondrial DNA tRNA(Lys) gene.
Zeviani M; Muntoni F; Savarese N; Serra G; Tiranti V; Carrara F; Mariotti C; DiDonato S
Eur J Hum Genet; 1993; 1(1):80-7. PubMed ID: 8069654
[TBL] [Abstract][Full Text] [Related]
15. A mitochondrial tRNA(Val) gene mutation (G1642A) in a patient with mitochondrial myopathy, lactic acidosis, and stroke-like episodes.
de Coo IF; Sistermans EA; de Wijs IJ; Catsman-Berrevoets C; Busch HF; Scholte HR; de Klerk JB; van Oost BA; Smeets HJ
Neurology; 1998 Jan; 50(1):293-5. PubMed ID: 9443499
[TBL] [Abstract][Full Text] [Related]
16. Pathophysiology of the MELAS 3243 transition mutation.
Flierl A; Reichmann H; Seibel P
J Biol Chem; 1997 Oct; 272(43):27189-96. PubMed ID: 9341162
[TBL] [Abstract][Full Text] [Related]
17. A MELAS syndrome family harboring two mutations in mitochondrial genome.
Choi BO; Hwang JH; Kim J; Cho EM; Cho SY; Hwang SJ; Lee HW; Kim SJ; Chung KW
Exp Mol Med; 2008 Jun; 40(3):354-60. PubMed ID: 18587274
[TBL] [Abstract][Full Text] [Related]
18. Atypical MELAS syndrome associated with a new mitochondrial tRNA glutamine point mutation.
Bataillard M; Chatzoglou E; Rumbach L; Sternberg D; Tournade A; Laforêt P; Jardel C; Maisonobe T; Lombès A
Neurology; 2001 Feb; 56(3):405-7. PubMed ID: 11171912
[TBL] [Abstract][Full Text] [Related]
19. The mitochondrial DNA G13513A transition in ND5 is associated with a LHON/MELAS overlap syndrome and may be a frequent cause of MELAS.
Pulkes T; Eunson L; Patterson V; Siddiqui A; Wood NW; Nelson IP; Morgan-Hughes JA; Hanna MG
Ann Neurol; 1999 Dec; 46(6):916-9. PubMed ID: 10589546
[TBL] [Abstract][Full Text] [Related]
20. Mutations in the ND5 subunit of complex I of the mitochondrial DNA are a frequent cause of oxidative phosphorylation disease.
Blok MJ; Spruijt L; de Coo IF; Schoonderwoerd K; Hendrickx A; Smeets HJ
J Med Genet; 2007 Apr; 44(4):e74. PubMed ID: 17400793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
